<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE245nnn/GSE245857/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245857</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Hepatic stellate cell-derived thrombospondin-2 as a novel therapeutic target for liver fibrosis</name><description>The in vivo effects of silencing Thbs2 in hepatic stellate cells (HSCs) were examined using an adeno-associated virus vector (serotype 6, AAV6) containing short hairpin RNAs (shRNAs) targeting Thbs2, under the regulatory control of cytomegalovirus (CMV) or smooth muscle α-actin (αSMA) promoter, in carbon tetrachloride (CCl4) induced liver fibrosis mouse models. Bulk RNA-seq of liver tissues from AAV6-CMV-shThbs2 mice or AAV6-αSMA mice and their controls was performed.</description><dates><publication>2026/04/01</publication></dates><accession>GSE245857</accession><cross_references><GSM>GSM7849979</GSM><GSM>GSM7849977</GSM><GSM>GSM7849978</GSM><GSM>GSM7849976</GSM><GSM>GSM7849982</GSM><GSM>GSM7849983</GSM><GSM>GSM7849980</GSM><GSM>GSM7849981</GSM><GPL>28330</GPL><GPL>17021</GPL><GSE>245857</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>